A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
Public ClinicalTrials.gov record NCT03934099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group, Placebo and Active Comparator-controlled, Dose Finding, and Phase II Study to Assess Efficacy and Safety of LC350189 in Gout Patients With Hyperuricemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this 12-week randomized multicenter double-blind parallel group placebo-controlled dose finding study is to assess the efficacy and safety of three different doses of LC350189 in subjects with hyperuricemia and a diagnosis of gout.
Study identification
- NCT ID
- NCT03934099
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2019 (Actual)
- Primary completion
- May 3, 2021 (Actual)
- Completion
- May 17, 2021 (Actual)
- Last update posted
- Dec 3, 2025
2019 – 2021
United States locations
- U.S. sites
- 34
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Synexus Clinical Research | Birmingham | Alabama | 35211 | — |
| Synexus Clinical Research | Chandler | Arizona | 85224 | — |
| Synexus Clinical Research | Mesa | Arizona | 85206 | — |
| Synexus Clinical Research | Tucson | Arizona | 85712 | — |
| Preferred Research Partner | Little Rock | Arkansas | 72211 | — |
| Health Awareness Inc | Jupiter | Florida | 33458 | — |
| Meridien Research | Maitland | Florida | 32751 | — |
| Miami Dade Medical Research Institute | Miami | Florida | 33176 | — |
| Meridien Research | St. Petersburg | Florida | 33709 | — |
| Clinical Research Trials of Florida, Inc | Tampa | Florida | 33607 | — |
| Avita Clinical Trials | Tampa | Florida | 33613 | — |
| IACT Health | Columbus | Georgia | 31904 | — |
| Synexus Clinical Research | Chicago | Illinois | 60602 | — |
| Synexus Clinical Research | Richfield | Minnesota | 55423 | — |
| Olive Branch Family Medical Cente | Olive Branch | Mississippi | 38654 | — |
| Synexus Clinical Research | St Louis | Missouri | 63141 | — |
| Quality Clinical Research | Omaha | Nebraska | 68114 | — |
| Synexus Clinical Research | Omaha | Nebraska | 68144 | — |
| Synexus Clinical Research | Henderson | Nevada | 89052 | — |
| OnSite Clinical Solutions | Charlotte | North Carolina | 28226 | — |
| OnSite Clinical Solutions | Charlotte | North Carolina | 28277 | — |
| Synexus Clinical Research | Akron | Ohio | 44311 | — |
| Synexus Clinical Research | Cincinnati | Ohio | 45236 | — |
| Synexus Clinical Research | Columbus | Ohio | 43212 | — |
| Paramount Medical Research and Consulting | Middleburg Heights | Ohio | 44130 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Synexus Clinical Research | Anderson | South Carolina | 29621 | — |
| Avant Research Associates | Austin | Texas | 78704 | — |
| Synexus Clinical Research | Dallas | Texas | 75234 | — |
| Discovery MM Services Incorporated | Houston | Texas | 77450 | — |
| Synexus Clinical Research | San Antonio | Texas | 78229 | — |
| Synexus Clinical Research | Salt Lake City | Utah | 84123 | — |
| Advanced Clinical Research | West Jordan | Utah | 84088 | — |
| Dominion Medical Associates | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03934099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2025 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03934099 live on ClinicalTrials.gov.